Skip to main content
SpringerLink
Log in

Early Neurological Deterioration

  • Chapter
Management of Post-Stroke Complications

  • 2564 Accesses

Abstract

Early neurological deterioration is common after acute stroke and is associated with increased disability and mortality. There are a number of mechanisms involved with neurological deterioration which can be divided into firstly, neurological causes as a result of the direct consequence of the neurological insult to the brain, and secondly, non-neurological causes such as abnormal physiological parameters. Both of these mechanisms can lead to secondary neuronal damage within the ischaemic penumbra. Many of these factors are potentially reversible, and therefore it is crucial that appropriate monitoring is undertaken to identify high risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic stroke; predictors, mechanisms and management. Postgrad Med J. 2008;84:412–7.

    Article  CAS  PubMed  Google Scholar 

  2. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J, for the ECASS Group. Neurological deterioration in acute ischaemic stroke. Potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke. 1999;30:2631–6.

    Google Scholar 

  3. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama M, Fukuzawa M. Deteriorating ischaemic stroke in 4 clinical categories classified by the Oxfordshire community stroke project. Stroke. 2000;31:2049–54.

    Article  CAS  PubMed  Google Scholar 

  4. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. Q J Med. 2006;99:625–33.

    Article  CAS  Google Scholar 

  5. Sumer M, Ozdemir I, Erturk O. Progression in acute ischaemic stroke: frequency, risk factors and prognosis. J Clin Neurosci. 2003;10:177–8080.

    Article  PubMed  Google Scholar 

  6. Castillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis. 1999;9:1–8.

    Article  PubMed  Google Scholar 

  7. Bhalla A, Wolfe CDA, Rudd AG. Management of acute physiological parameters after stroke. Q J Med. 2001;94:167–72.

    Article  CAS  Google Scholar 

  8. Langhorne P, Stott DJ, Robertson L, MacDonald, Jones L, McAlpine C, Dick F, Taylor GS, Murray G. Medical complications after stroke. A multicentre study. Stroke. 2000;31:1223–99.

    Article  CAS  PubMed  Google Scholar 

  9. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS, Bleich HL. The Harvard cooperative stroke registry: a prospective registry. Neurology. 1978;28:754–62.

    Article  CAS  PubMed  Google Scholar 

  10. Steinke W, Ley SC. Lacunar stroke is the major cause of the progressive motor deficits. Stroke. 2002;62:393–77.

    Google Scholar 

  11. Bhalla A, Hargroves D. Does early medical management have a role in the management of intracerebral haemorrhage? Int J Clin Pract. 2008;62:633–41.

    Article  CAS  PubMed  Google Scholar 

  12. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ. Progression in acute stroke: value of the initial NIH stroke scale score on patient satisfaction in future trials. Stroke. 1999;30:1208–12.

    Article  CAS  PubMed  Google Scholar 

  13. Berger C, Fiorelli M, Steiner T, Shabitz WR, Bozzao L, Bluhmki E, et al. Haemorrhagic transformation of ischaemic brain tissue. Asymptomatic or symptomatic? Stroke. 2001;32:1330–55.

    Article  CAS  PubMed  Google Scholar 

  14. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC, The German Stroke Study Collaboration. Neurologic worsening during the acute phase of ischaemic stroke. Arch Neurol. 2005;62:393–77.

    Article  PubMed  Google Scholar 

  15. Tissue plasminogen activator for acute ischaemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–7.

    Google Scholar 

  16. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Haemorrhagic transformation in acute ischaemic stroke. Potential contributing factors in the European cooperative acute stroke study. Stroke. 1997;28:957–6060.

    Article  CAS  PubMed  Google Scholar 

  17. Saver JL. Haemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke. 2007;38:2279–8383.

    Article  CAS  PubMed  Google Scholar 

  18. Holtmannspotter M, Schoch A, Baethmann A, Reulen HJ, Uhl E. Intracranial hypertension influences the resolution of vasogenic brain oedema following intracerebral haemorrhage. Acta Neurochir Suppl. 2000;76:497–99.

    CAS  PubMed  Google Scholar 

  19. Sacco C, Marini C, Carolei. Medical treatment of intracerebral haemorrhage. Neurol Sci. 2004;25 Suppl 1:S6–99.

    Article  PubMed  Google Scholar 

  20. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59:862–7.

    Article  CAS  PubMed  Google Scholar 

  21. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–2222.

    Article  PubMed  Google Scholar 

  22. Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al. Predictors of early arterial occlusion after tissue plasminogen activator induced recanalisation in acute ischaemic stroke. Stroke. 2005;36:1452–66.

    Article  PubMed  Google Scholar 

  23. Ali LK, Saver JL. The ischaemic stroke patient who worsens: new assessment and management approaches. Rev Neurol Dis. 2007;4:85–91.

    PubMed  Google Scholar 

  24. Hankey GJ. Secondary prevention of stroke. Lancet Neurol. 2014;13(2):178–94.

    Article  PubMed  Google Scholar 

  25. Caplan LR. Worsening in ischaemic stroke patients: is it time for a new strategy? Stroke. 2002;33:1443–55.

    Article  CAS  PubMed  Google Scholar 

  26. Pulsinelli W. Pathophysiology of acute ischaemic stroke. Lancet. 1992;339:533–66.

    Article  CAS  PubMed  Google Scholar 

  27. Markus HS. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry. 2004;75:353–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Indredavik B, Bakke RPT, Slordahl SA, Rokseth R, Haheim LL. Treatment in a combined acute and rehabilitation stroke unit. Which aspects are most important? Stroke. 1999;30:917–2323.

    Article  CAS  PubMed  Google Scholar 

  29. Ronning OM, Guldvog B. Stroke unit versus medical wards, II: neurological deficits and activities of daily living. A quasi randomised controlled trial. Stroke. 1998;29:586–9090.

    Article  CAS  PubMed  Google Scholar 

  30. Davis M, Hollyman C, McGiven M, Chambers I, Egbuji J, Barer D. Physiological monitoring in acute stroke. Age Ageing. 1999;28(Suppl):4.

    Google Scholar 

  31. Fisher M. Characterising the target of acute stroke therapy. Stroke. 1997;28:866–7272.

    Article  CAS  PubMed  Google Scholar 

  32. Guidelines for management of ischaemic stroke and transient ischaemic attack: the European Stroke Organisation (ESO) Executive Committee, and the ESO Writing Committee. Cerebrovasc Dis. 2008;25:457–507.

    Google Scholar 

  33. Walshaw MJ, Pearson MG. Hypoxia in patients with acute hemiplegia. Br Med J. 1984;228:15–77.

    Article  Google Scholar 

  34. Elizabeth J, Singarayar J, Ellul J, Barer D, Lye M. Arterial oxygen saturation and posture in acute stroke. Age Ageing. 1993;22:269–72.

    Article  CAS  PubMed  Google Scholar 

  35. Bhalla A, Pomeroy VM, Tallis RC. The effects of positioning after stroke on physiological homeostasis: a review. Age Ageing. 2005;34:401–66.

    Article  CAS  PubMed  Google Scholar 

  36. Mickel HS, Vaishnav YN, Kempski O, von Lubitz D, Weiss JF, Feuertein G. Breathing 100% oxygen after global brain ischaemia in Mongolian gerbils results in increased lipid peroxidation and increased mortality. Stroke. 1987;18:426–30.

    Article  CAS  PubMed  Google Scholar 

  37. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi randomised controlled trial. Stroke. 1999;30:2033–7.

    Article  CAS  PubMed  Google Scholar 

  38. Roffe C, Nevatte T, Crome P, Gray R, Sim J, Pountain S, et al. The stroke oxygen pilot study; a multicentre prospective randomised open, blinded endpoint study of routine oxygen treatment in the first 72 hours after a stroke (SO2S). 2014. http://www.so2s.co.uk.

  39. Harrison MJ. The influence of haematocrit in the cerebral circulation. Cerebrovasc Brain Metab Rev. 1989;1:55–67.

    CAS  PubMed  Google Scholar 

  40. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CDA, Rudd AG. The influence of raised plasma osmolality on clinical outcome after stroke. Stroke. 2000;31:2043–88.

    Article  CAS  PubMed  Google Scholar 

  41. Asplund K, Israelsson K, Schampi I. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev. 2000;2:CD000103.

    Google Scholar 

  42. Weir JW, Murria GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after stroke? Results of a long term follow up study. BMJ. 1997;314:1303–66.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen stroke study. Stroke. 1994;25:1977–84.

    Article  CAS  PubMed  Google Scholar 

  44. Helgason CM. Blood glucose and stroke. Stroke. 1988;19:1049–5353.

    Article  CAS  PubMed  Google Scholar 

  45. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke. 2004;35:363–4.

    Article  PubMed  Google Scholar 

  46. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:349–5353.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263–7070.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Fuentes B, Castillo J, San José B, Leira R, Serena J, Vivancos J, et al. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in acute stroke (GLIAS) study. Stroke. 2009;40:562–88.

    Article  CAS  PubMed  Google Scholar 

  49. Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NEF, et al., for the GIST Trialists Collaboration. Glucose–potassium–insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol. 2007;6:397–406.

    Google Scholar 

  50. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS). A randomised pilot trial. Stroke. 2008;39:384–99.

    Article  CAS  PubMed  Google Scholar 

  51. Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American Academy of neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–711.

    Article  PubMed  Google Scholar 

  52. Britton M, Carlsson A, De Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986;17:861–44.

    Article  CAS  PubMed  Google Scholar 

  53. Britton M, Carlsson A. Very high blood pressure in acute stroke. J Intern Med. 1990;228:611–55.

    Article  CAS  PubMed  Google Scholar 

  54. Robinson T, Waddington A, Ward Close S, Taub N, Potter J. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis. 1997;7:264–7272.

    Article  Google Scholar 

  55. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, IST Collaborative Group. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;23:1315–2020.

    Article  Google Scholar 

  56. He J, Zhang Y, Xu T, Zhao Q, Wang D, Chen CS, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischaemic stroke. The CATIS randomised clinical trial. JAMA. 2014;311(5):479–89.

    Article  CAS  PubMed  Google Scholar 

  57. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of acute candesartan ciliexetil therapy in stroke survivors. Stroke. 2003;34:1699–703.

    Google Scholar 

  58. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately postsroke (CHHIPS): a randomised placebo controlled double blind pilot trials. Lancet Neurol. 2009;8:48–56.

    Article  CAS  PubMed  Google Scholar 

  59. Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, et al., COSSACS Trial Group. COSSACS (continue or stop post-stroke antihypertensives collaborative study). Lancet Neurol. 2010;9(8):767–75.

    Google Scholar 

  60. Sandest E, Bath PMW, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled double blind trial. Lancet. 2011;377:741–5050.

    Article  Google Scholar 

  61. Hill MD, Muir KW. INTERACT 2. Should blood pressure be aggressively lowered acutely after intracerebral haemorrhage? Stroke. 2013;44:2951–22.

    Article  PubMed  Google Scholar 

  62. Rodorf G, Cranmer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke. Stroke. 1997;28:2133–8.

    Article  Google Scholar 

  63. Hajat C, Hajat S, Sharma P. Effects of post stroke pyrexia on stroke outcome. A meta-analysis of studies in patients. Stroke. 2000;31:410–4.

    Article  CAS  PubMed  Google Scholar 

  64. Deogaonkar A, De Georgia, Bae C, et al. Fever is associated with third ventricular shift after intracerebral haemorrhage: pathophysiologic implications. Neurol India. 2005;53:202–6.

    Article  PubMed  Google Scholar 

  65. Leira R, Dávalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, et al. Early neurologic deterioration in intracerebral haemorrhage: predictors and associated factors. Neurology. 2004;63:461–7.

    Article  CAS  PubMed  Google Scholar 

  66. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke. 1998;29:2461–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ageing and Health, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

    Ajay Bhalla MSc, MD, FRCP

Authors
  1. Ajay Bhalla MSc, MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ajay Bhalla MSc, MD, FRCP .

Editor information

Editors and Affiliations

  1. Department of Ageing and Health, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

    Ajay Bhalla

  2. Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

    Jonathan Birns

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bhalla, A. (2015). Early Neurological Deterioration. In: Bhalla, A., Birns, J. (eds) Management of Post-Stroke Complications. Springer, Cham. https://doi.org/10.1007/978-3-319-17855-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17855-4_2

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17854-7

  • Online ISBN: 978-3-319-17855-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation